BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Novalar Pharmaceuticals, Inc. 

12555 High Bluff Drive
Suite 300
San Diego  California  92130  U.S.A.
Phone: 858-436-1100 Fax: 858-436-1101


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Novalar Pharmaceuticals, Inc. Plans Shutdown Following Sale of OraVerse to Septodont, to Cut 12 Jobs 3/23/2011 7:05:49 AM    More...
Novalar Pharmaceuticals, Inc. Announces Acquisition of OraVerse(R) by Septodont 3/21/2011 8:38:29 AM    More...
Novalar Pharmaceuticals, Inc. Makes OraVerse(R) Product Donation to National Children's Oral Health Foundation 12/1/2010 7:09:10 AM    More...
Sanofi-Aventis (France) (SASY.PA) And Novalar Pharmaceuticals, Inc. File Marketing Authorization Application for OraVerse(R) in Five Key European Countries 7/14/2010 11:47:52 AM    More...
Novalar Pharmaceuticals, Inc. Reaches Agreement With H.A. Systems to Distribute OraVerse(R) in Israel 5/17/2010 9:54:45 AM    More...
Novalar Pharmaceuticals, Inc. Presents Results of OraVerse(R) Dental Practice Survey at American Association of Dental Research Meeting 3/5/2010 9:55:46 AM    More...
Sanofi-Aventis (France) (SASY.PA) and Novalar Pharmaceuticals, Inc. Enter Exclusive License Agreement to Commercialize OraVerse(R) in Germany 3/3/2010 9:00:46 AM    More...
Novalar Pharmaceuticals, Inc. Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent; Hires Additional 27 2/27/2009 12:03:38 PM    More...
Novalar Pharmaceuticals, Inc. Receives FDA Approval for OraVerse(TM) 5/12/2008 6:31:57 AM    More...
Novalar Pharmaceuticals, Inc. Strengthens Senior Management Team With Key Appointments 12/18/2007 8:43:39 AM    More...
12

//-->